Cardinal Health Inc (CAH) stock
CAHNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 16/3040% above fair value
$272.81+0.47 (+0.17%)
Close on Nov 20, 2026Market cap $63.45BP/E 37.7Yield 0.75%
Cardinal Health free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Cardinal Health's free cash flow for the twelve months ending Jun 30, 2026 was $4.53B, up 144.6% year over year. For fiscal 2026 it was $4.53B, up 144.6% from the year before. Over ten years it grew 6.1% a year on average. The highest annual figure on record is $4.53B in fiscal 2026.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $4.53B | +144.6% |
| FY2025 | Jun 30, 2025 | $1.85B | -43.1% |
| FY2024 | Jun 30, 2024 | $3.25B | +37.6% |
| FY2023 | Jun 30, 2023 | $2.36B | -15.2% |
| FY2022 | Jun 30, 2022 | $2.79B | +37.4% |
| FY2021 | Jun 30, 2021 | $2.03B | +28.0% |
| FY2020 | Jun 30, 2020 | $1.59B | -33.8% |
| FY2019 | Jun 30, 2019 | $2.39B | +0.4% |
| FY2018 | Jun 30, 2018 | $2.38B | +199.1% |
| FY2017 | Jun 30, 2017 | $797.00M | -68.2% |
| FY2016 | Jun 30, 2016 | $2.51B | +11.9% |
| FY2015 | Jun 30, 2015 | $2.24B | -1.5% |
| FY2014 | Jun 30, 2014 | $2.28B | +48.5% |
| FY2013 | Jun 30, 2013 | $1.53B | +67.2% |
| FY2012 | Jun 30, 2012 | $916.00M | -17.0% |
| FY2011 | Jun 30, 2011 | $1.10B | -41.1% |
| FY2010 | Jun 30, 2010 | $1.87B | +86.9% |
| FY2009 | Jun 30, 2009 | $1.00B | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $1.43B | +10.9% |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | $1.68B | -40.0% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $555.00M | – |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $865.00M | – |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $1.29B | -31.8% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $2.79B | – |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | -$495.00M | -146.5% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | -$1.74B | -498.4% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $1.89B | +192.4% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | -$139.00M | -111.1% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $1.07B | +108.0% |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $436.00M | – |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $646.00M | -77.6% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $1.25B | – |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $512.00M | -54.3% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | -$47.00M | – |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $2.88B | +434.5% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | -$501.00M | -383.1% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $1.12B | 0.0% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | -$713.00M | -471.4% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $539.00M | +418.3% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $177.00M | -88.8% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $1.12B | +80.8% |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | $192.00M | – |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $104.00M | -71.9% |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $1.59B | +13.0% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $620.00M | +98.1% |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | -$725.00M | -336.2% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $370.00M | -11.1% |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | $1.40B | +107.7% |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | $313.00M | +75.8% |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | $307.00M | -72.4% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $416.00M | -34.0% |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | $676.00M | – |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | $178.00M | -59.6% |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | $1.11B | +27750.0% |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $630.00M | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | -$278.00M | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | $441.00M | – |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | $4.00M | – |
See a number that looks wrong?